Science Explorer Back to mapMap
Discussion
Company · Ann Arbor · United States

Essen BioScience (United States)

Research works
36
▼ 90% vs 2018-21
Citations
268
7.5 per fractional work
Top-10% rate
9.4%
all institutions 10.0%
Open access
16%
world 40%
International
19%
world 18%

Not ranked overall: Essen BioScience (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Essen BioScience (United States) work in?

In all years, 55% of research at Essen BioScience (United States) is in Life Sciences, 32% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (40%), Medicine (30%), Immunology and Microbiology (13%). It does 2.7× the world's share of Life Sciences.

Life Sciences: 20 fractional works · 54.8% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 39.8% of its workMolecular Biology: 8 fractional works · 21.2% of its workCancer Research: 3 fractional works · 8.6% of its workBiophysics: 2 fractional works · 5.1% of its workBiotechnology: 1 fractional works · 1.9% of its workCell Biology: 1 fractional works · 1.9% of its workBiochemistry: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.4% of its workMolecular Medicine: 0 fractional works · 0.3% of its workImmunology and Microbiology: 5 fractional works · 12.8% of its workImmunology: 5 fractional works · 12.8% of its workNeuroscience: 1 fractional works · 2.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.1% of its workBiological Psychiatry: 0 fractional works · 0.9% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workHealth Sciences: 11 fractional works · 31.5% of its workMedicine: 11 fractional works · 29.8% of its workOncology: 5 fractional works · 14.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.0% of its workImmunology and Allergy: 1 fractional works · 3.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.7% of its workPathology and Forensic Medicine: 0 fractional works · 1.2% of its workGenetics: 0 fractional works · 0.8% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.8% of its workEpidemiology: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.4% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workRheumatology: 0 fractional works · 0.3% of its workSurgery: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 1 fractional works · 1.7% of its workGeneral Health Professions: 0 fractional works · 1.4% of its workRadiological and Ultrasound Technology: 0 fractional works · 0.3% of its workPhysical Sciences: 5 fractional works · 13.4% of its workEngineering: 3 fractional works · 9.5% of its workBiomedical Engineering: 3 fractional works · 9.5% of its workChemical Engineering: 0 fractional works · 1.2% of its workBioengineering: 0 fractional works · 0.9% of its workChemical Health and Safety: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 1.2% of its workBiomaterials: 0 fractional works · 1.2% of its workEnvironmental Science: 0 fractional works · 0.9% of its workEcology: 0 fractional works · 0.9% of its workMathematics: 0 fractional works · 0.5% of its workModeling and Simulation: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.3% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.3% of its workALL ITS WORKEssen BioScience(United States)36fractional works, all years
Life Sciences55%Physical Sciences13%Health Sciences32%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1439.8%
    2. Immunology and Microbiology512.8%
    3. Neuroscience12.0%
    4. Agricultural and Biological Sciences00.2%
    1. Medicine1129.8%
    2. Health Professions11.7%
    1. Engineering39.5%
    2. Chemical Engineering01.2%
    3. Materials Science01.2%
    4. Environmental Science00.9%
    5. Mathematics00.5%
    1. Decision Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Essen BioScience (United States)?

Ranked on the quality score, Clare Szybut, Hinnah Campwala and Tim Dale lead among researchers whose main affiliation is Essen BioScience (United States).

  1. 1 Clare Szybut United States · #3,081,490 worldwide 1 citations · 16 works
  2. 2 Hinnah Campwala United States · #3,375,506 worldwide 171 citations · 21 works
  3. 3 Tim Dale United States · #4,073,635 worldwide 332 citations · 40 works
All ranked researchers at Essen BioScience (United States)

What are the most cited papers from Essen BioScience (United States)?

The most cited paper from Essen BioScience (United States) is "IonWorks™ HT: A New High-Throughput Electrophysiology Measurement Platform" (Kirk S. Schroeder, Brad Neagle, Derek J. Trezise et al., 2003), with 222 citations. Next come "High Throughput Ion-Channel Pharmacology: Planar-Array-Based Voltage Clamp" (121) and "A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors" (52).

Most cited papers
#PaperReleasedCitations
1 IonWorks™ HT: A New High-Throughput Electrophysiology Measurement Platform Kirk S. Schroeder, Brad Neagle, Derek J. Trezise et al. · SLAS DISCOVERY Open access 2003 222
2 High Throughput Ion-Channel Pharmacology: Planar-Array-Based Voltage Clamp László Kiss, Paul B. Bennett, Victor N. Uebele et al. · Assay and Drug Development Technologies Feb 2003 121
3 A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors Mari Carmen Vazquez-Borrego et al. · Clinical Cancer Research 17 Oct 2019 52
4 HTS assays for developing the molecular pharmacology of ion channels Owen B. McManus · Current Opinion in Pharmacology Review 18 Feb 2014 44
5 A Multiplexed Method for Kinetic Measurements of Apoptosis and Proliferation Using Live-Content Imaging Katherine A. Artymovich, Daniel M. Appledorn · Methods in molecular biology Book chapter 18 Sep 2014 36
All 32 most cited papers, with filters and sorting

Which keywords describe research at Essen BioScience (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Immunotherapy, Immunity, Inflammation, Cancer Immunotherapy, Targeted Therapy, Microfluidic Devices and Tissue Engineering.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer4▲ 7.9×8 topics
  2. Inflammation4▲ 4.2×4 topics
  3. Immunotherapy3▲ 13×7 topics
  4. Immunity3▲ 23×3 topics
  5. Cancer Immunotherapy3▲ 52×3 topics
  6. Targeted Therapy2▲ 31×4 topics
  7. Microfluidic Devices2▲ 78×2 topics
  8. Tissue Engineering2▲ 12×4 topics
  9. Cell Culture2▲ 57×3 topics
  10. Regenerative Medicine2▲ 28×3 topics
  11. Angiogenesis2▲ 14×4 topics
  12. Hydrogels2▲ 43×2 topics
  13. Bioinks2▲ 122×1 topic
  14. Bioprinting2▲ 122×1 topic
  15. Nanoparticles2▲ 4.2×4 topics
  16. Cancer Stem Cells2▲ 121×1 topic
  17. Tumor Metastasis2▲ 87×1 topic
  18. Tumor Regression2▲ 62×2 topics
  19. Cancer Genomics2▲ 91×1 topic
  20. Extracellular Matrix2▲ 21×4 topics
  21. Metabolism2▲ 7.8×3 topics
  22. Mutational Signatures2▲ 91×1 topic
  23. Tumor Targeting2▲ 35×3 topics
  24. High-Throughput Analysis2▲ 91×1 topic
  25. Ion Channels2▲ 19×2 topics
  26. Protein Microarrays2▲ 211×1 topic
  27. Reactive Oxygen Species2▲ 8.4×4 topics
  28. Activation1▲ 115×1 topic
  29. Cancer Therapy1▲ 6.1×5 topics
  30. Gene Expression1▲ 6.3×4 topics
  31. Macrophage1▲ 71×1 topic
  32. Biosensors1▲ 6.5×3 topics
  33. CAR T Cells1▲ 81×1 topic
  34. Cell Adhesion1▲ 41×1 topic
  35. Chimeric Antigen Receptor1▲ 81×1 topic
  36. Integrins1▲ 61×1 topic
  37. VEGF1▲ 103×1 topic
  38. endothelial progenitor cells1▲ 103×1 topic
  39. Glycosylation1▲ 15×2 topics
  40. Cell Signaling1▲ 8.9×2 topics

Which research topics does Essen BioScience (United States) publish most on?

By volume in 2022-now: Advanced biosensing and bioanalysis techniques, Innovative Microfluidic and Catalytic Techniques Innovation, PARP inhibition in cancer therapy and Biosensors and Analytical Detection.

  1. 1 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  2. 2 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
  3. 3 PARP inhibition in cancer therapy Oncology 0 works
  4. 4 Biosensors and Analytical Detection Biomedical Engineering 0 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 0 works
  6. 6 Molecular Biology Techniques and Applications Molecular Biology 0 works
  7. 7 vaccines and immunoinformatics approaches Molecular Biology 0 works
  8. 8 Single-cell and spatial transcriptomics Molecular Biology 0 works
  9. 9 Gene expression and cancer classification Molecular Biology 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available16.3%not open83.7%

World: 40% of research is openly available.

with international co-authors19.0%domestic only81.0%

World: 18% is written across borders.

How has Essen BioScience (United States)'s research output changed?

Output in 2022-2025 was 90% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Essen BioScience (United States) as a percentage of every work published that year, 0.0000060% in 2024.

still counting0.000050%0.00010%0.00015%Essen BioScience (United States)0.0000043% in 202520102020

Fractional works of Essen BioScience (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Ann Arbor

All research institutions in Ann Arbor

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Essen BioScience (United States). Posts are plain text and can be reported.